Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report
eJHaem · 2026-10 · 7 (5)
DOI: 10.1002/jha2.70423 ↗Kurz gefasst
Fallbericht in der Zeitschrift eJHaem, online erschienen am 09.10.2026. Verfasst von Zachray Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eastern Health Box Hill Victoria Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Although Immune cytopenias such as immune thrombocytopenia (ITP), autoimmune haemolytic anaemia (AIHA) and pure red blood cell aplasia (PRCA) are well documented associations with chronic lymphocytic leukaemia (CLL), aplastic anaemia (AA) is seemingly rare. Case This report describes a case of AA in a CLL patient post commencement of acalabrutinib, a bruton tyrosine kinase inhibitor (BTKi).
Discussion
We further evaluate the current literature surrounding AA in concurrent lymphoproliferative disorders as well as previous cases in the setting of tyrosine kinase inhibition. Highlighting the potential pathophysiological pathways of T regulatory cell dysfunction resulting in immune targeting of haematopoietic stem progenitor cells, we explore the resultant AA as an aberrant immune response secondary to CLL and/or the inhibition of BTKi. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eastern Health Box Hill Victoria Australia.
Zitieren
APA
Wei, Z., Marconi, T., Tuck, L., & Ting, S. (2026). Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report. eJHaem, 7(5). https://doi.org/10.1002/jha2.70423
Vancouver
Wei Z, Marconi T, Tuck L, Ting S. Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report. eJHaem. 2026;7(5). doi:10.1002/jha2.70423
BibTeX
@article{Wei2026,
author = {Wei, Zachray and Marconi, Tamara and Tuck, Lucy and Ting, Stephen},
title = {Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report},
journal = {eJHaem},
year = {2026},
volume = {7},
number = {5},
doi = {10.1002/jha2.70423}
}
EUVIMED